Consistent with previous studies showing that OMV-based vaccine was capable of conferring both long-lasting immunity and protection against pertussis (Gaillard et al., 2014), here we demonstrated that OMV-based vaccine was also effective at inducing respiratory INF-γ- and IL-17-secreting TRM cells. The gene discussed is IL17A; the disease is pertussis.